1. Home
  2. OCUL vs EDN Comparison

OCUL vs EDN Comparison

Compare OCUL & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • EDN
  • Stock Information
  • Founded
  • OCUL 2006
  • EDN 1992
  • Country
  • OCUL United States
  • EDN Argentina
  • Employees
  • OCUL N/A
  • EDN N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • EDN Electric Utilities: Central
  • Sector
  • OCUL Health Care
  • EDN Utilities
  • Exchange
  • OCUL Nasdaq
  • EDN Nasdaq
  • Market Cap
  • OCUL 1.2B
  • EDN 1.3B
  • IPO Year
  • OCUL 2014
  • EDN 2007
  • Fundamental
  • Price
  • OCUL $7.27
  • EDN $30.64
  • Analyst Decision
  • OCUL Strong Buy
  • EDN
  • Analyst Count
  • OCUL 9
  • EDN 0
  • Target Price
  • OCUL $16.22
  • EDN N/A
  • AVG Volume (30 Days)
  • OCUL 1.8M
  • EDN 106.6K
  • Earning Date
  • OCUL 03-03-2025
  • EDN 03-11-2025
  • Dividend Yield
  • OCUL N/A
  • EDN N/A
  • EPS Growth
  • OCUL N/A
  • EDN 42.19
  • EPS
  • OCUL N/A
  • EDN 0.30
  • Revenue
  • OCUL $63,723,000.00
  • EDN $1,981,694,257.00
  • Revenue This Year
  • OCUL $14.02
  • EDN $51.74
  • Revenue Next Year
  • OCUL $15.47
  • EDN N/A
  • P/E Ratio
  • OCUL N/A
  • EDN $6.35
  • Revenue Growth
  • OCUL 9.03
  • EDN 33.82
  • 52 Week Low
  • OCUL $4.06
  • EDN $13.78
  • 52 Week High
  • OCUL $11.78
  • EDN $51.69
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 45.35
  • EDN 38.68
  • Support Level
  • OCUL $7.36
  • EDN $31.20
  • Resistance Level
  • OCUL $8.04
  • EDN $35.20
  • Average True Range (ATR)
  • OCUL 0.45
  • EDN 1.78
  • MACD
  • OCUL -0.02
  • EDN -0.00
  • Stochastic Oscillator
  • OCUL 13.61
  • EDN 19.63

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.

Share on Social Networks: